Two Healthcare Stocks That Investors Should Keep in Portfolio


SINGAPORE – Many portfolio supervisors recommend adding a few safe stocks when building your investment portfolio and investing in stocks. A safe bet is one that can thrive even in times of monetary downturn. Protective stocks don’t just protect your portfolio, but they also serve as support in the midst of bear markets. The healthcare industry is seen as a protective industry because healthcare is a necessary part of everyday existence.

So having health stocks to fight your wallet can be a smart idea. All things considered, there are two health stocks in Singapore that are having a good growth rate.


International Specialist Eye Center (ISEC) is listed in SGX in 2014. The company is located in Centrepoint South Mid Valley Kuala Lumpur, Penang Jalan Burma and Lee Hung Ming Eye Center are centers of excellence in ophthalmology, especially in clinical care , teaching and research.

The group offers expert services in therapeutic ophthalmology through its system of four eye foci in Malaysia and one at Gleneagles Hospital in Singapore. In 2016, the company expanded its administrations to incorporate general restorative administrations through the procurement of JLM Companies, which includes four facilities in the heart of Singapore.

The system has worked admirably, so the advice for stocks is to keep it in your wallet. In 2017, the organization revealed a 20% rebound in revenue and a 22% increase in net profit. 2018 has also started well, with revenue for the main quarter increasing by 14% while profits have increased year over year.

This has been attributed to a higher number of patients at its current centers, possibly due to the increase in referrals from its recently obtained facility system.

The company has also stated on several occasions that it intends to grow its land footprint locally in China and Vietnam, where the market for ophthalmic services is considerably larger than that of Malaysia and Singapore.

With their no-bond Perfect Asset Report and S $ 27 million in real money, the organization surely has the budget muscle to make more acquisitions or to establish a center in their target markets. Labor income also increases reliably alongside its bottom line. This can provide the organization with the accounts to make more acquisitions or to compensate investors with profits or propose buyouts.

Additionally, at a purchase price of $ 0.29 (in songwriting season), the organization is only estimated at 17.7 times its annualized profit and 2.23 times its accounting estimate. Beyond that, its offerings have a profit return of 4.1%, the third most notable return among human services stocks in Singapore.

Raffles Medical Group

Raffles Medical is the second largest registered healthcare administrator in Singapore. It has a system of general medicine facilities and a medical facility in Singapore. The company maybe has extraordinary compared to other development track record in Singapore.

This selection of Singapore stocks began in 1976 with just two centers. From that moment the company has grown at a rapid pace and now has a network of centers located in Singapore and other countries such as China, Japan, Vietnam and Cambodia.

The company has also started planning two new healing centers in China. It is a 700-bed medical facility in Chongqing and a 400-bed healing center in Shanghai. It also added a 20-story extension to its current healing center in Singapore in January this year, increasing its professional administrations and increasing its bed limit and facility space.

Surprisingly, Raffles Medical’s equity has accomplished this huge development in large part thanks to the money earned on tasks. In 2017, the organization generated approximately S $ 83 million in labor income.

Regardless of the huge investments required for the two new healing centers, Raffles Medical, as of March 31, 2018, only used S $ 72 million of bonds and had accumulated S $ 94 million, giving it a net monetary position of S $ 22 million.

Prospective financial experts should also be pleased to note that the organization’s Singapore stock trading has taken a serious hit in the market over the past two years. Bids are trading at just S $ 1.01 per coin, nearly 30% below its peak. Market members have been stressed by the stagnation of development of the main concern over the past two years due to the market’s immersion in its central market in Singapore.

Raffles Medical shares now have a price-to-earnings ratio of 25.2, a price-to-book ratio of 2.4 and a yield of 2.2%. These are alluring valuations, and long-term financial specialists who see any problem getting teeth into its new healing facilities will no doubt be compensated.

Hope this inventory update article has been helpful to you. Stay up to date with our Singapore Stocks Blog to receive the best Singapore investing and stocks signals.

Leave a comment in the comments section. Thank you!!

Source by Vineeta Sonone

Comments are closed.